Skip to main content
. 2017 Dec 1;131(4):387–396. doi: 10.1182/blood-2017-06-789800

Table 3.

TEAEs in ≥20% of all treated patients

Preferred term 40-µg/kg dose (N = 18) All treated patients (N=131)
All grades >Grade 3 All grades >Grade 3
Any event 100 100 100 96
Febrile neutropenia 72 72 57 57
Fatigue 56 11 49 10
Thrombocytopenia 50 25 44 40
Anemia 22 42 38 33
Nausea 39 34
Diarrhea 17 31 2
Decreased appetite 22 6 30 2
Peripheral edema 28 30 2
Dyspnea 44 6 29 7
Constipation 33 25
Epistaxis 22 24 2
Hypokalemia 11 24 5
Cough 28 22 1
Chills 33 21 1
Contusion 39 21
Pyrexia 17 20 1
Neutropenia 28 28 18 19
Asthenia 22 18 18

Dashes indicate that toxicity did not occur at higher than Grade 3.